BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Cancer Epigenetics Society - ECPv5.3.2.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Cancer Epigenetics Society
X-ORIGINAL-URL:https://ces.b2sg.org
X-WR-CALDESC:Events for Cancer Epigenetics Society
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20170326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20171029T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20171012
DTEND;VALUE=DATE:20171014
DTSTAMP:20260813T155449
CREATED:20170507T180546Z
LAST-MODIFIED:20171001T150750Z
UID:17891-1507766400-1507939199@ces.b2sg.org
SUMMARY:3rd Annual Epigenetics Discovery Congress in London\, UK
DESCRIPTION:After our two successful editions\, we are glad to announce the 3rd Annual Epigenetics Discovery Congress. \nWith a tremendous progress in technology to generate and analyze reference epigenomes\, the epigenetics field is fetching a lot of importance and attention across all medical science’s areas.  Additionally\, novel epigenetic molecules across many target classes for drug discovery\, have been the prime focus of the pharmaceutical industry. \nTo meet and support this pace of the epigenetics research and development field\, the 3rd Annual Epigenetics Discovery Congress will present novel research and address challenges right from molecular sciences & disease diagnosis to drug discovery streams. The congress will also be a great platform to learn about novel technologies like next generation sequencing and single cell analysis. \nSpeakers: \nPaola Arimondo\, ETaC\, France \nRoland Baumgartner\, 4SC\, Germany  \nCarlos Buesa\, Oryzon\, Spain \nSusan Clark\, Garvan Institute of Medical Research\, Sydney\, Australia \nJerome Dejardin\, MSH\, France \nJames Flanagan\, Imperial College London\, UK \nPetra Hajkova\, MRC Institute of Medical Sciences (LMS)\, UK \nJohn Holloway\, University of Southampton\, UK \nKilian Huber\, University of Oxford\, UK \nPaul Hurd\, Queen Mary University of London\, UK \nKaren Lillycrop\, University of Southampton\, UK \nGavin Kelsey\, The Babraham Institute\, UK \nGuro Lind\, University of Oslo\, Norway \nJelena Mann\, Newcastle University\, UK \nRab Prinjha\, GlaxoSmithKline\, UK \nJoëlle Rüegg\, Karolinska Institutet\, Sweden \nChristopher Schofield\, University of Oxford\, UK \nPaul Shiels\, University of Glasgow\, UK \nJesse Smith\, Epizyme\, USA \nRémi Terranova\, Novartis Institutes for BioMedical Research\, Switzerland \nMaria Toledo\, University of Nottingham\, United Kingdom \nJonathan Turner\, Luxembourg Institute of Health\, Luxembourg \nKatherine West\, University of Glasgow\, UK \nDavid M. Wilson\, Astrazeneca\, UK \n  \n  \n 
URL:https://ces.b2sg.org/event/3rd-epigenetics-congress-oct2017/
LOCATION:TBA\, London\, United Kingdom
CATEGORIES:Meetings
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/05/epigenetics-discovery-congress.jpeg
END:VEVENT
END:VCALENDAR